Indiana Administrative Code
Title 845 - BOARD OF PODIATRIC MEDICINE
Article 2 - OPIOID PRESCRIBING REQUIREMENTS
Rule 1 - General Provisions
Section 1-8 - Drug monitoring testing
Current through March 20, 2024
Authority: IC 25-22.5-13-3
Affected: IC 25-1-9; IC 25-29
Sec. 8.
(a) At any time the podiatrist determines that it is medically necessary, whether at the outset of an opioid treatment plan, or any time thereafter, a podiatrist prescribing opioids for a patient shall perform or order a drug monitoring test, which must include a confirmatory test using a method selective enough to differentiate individual drugs within a drug class, on the patient.
(b) In determining whether a drug monitoring test under subsection (a) is medically necessary, the podiatrist shall consider, subject to the provisions of subsection (c), each of the following factors where applicable and reasonably feasible:
(c) It shall not be considered a violation of this section for a podiatrist to fail to conduct a review of all eighteen (18) factors listed in subsection (b) if the podiatrist reasonably determines following a review of less than all of the factors listed in subsection (b) that a drug monitoring test is medically necessary.
(d) Nothing about subsection (b) shall be construed to prohibit the podiatrist from performing or ordering a drug monitoring test at any other time the podiatrist considers appropriate.
(e) If a test performed under subsection (a), or conducted under subsection (d), reveals inconsistent medication use patterns or the presence of illicit substances, a review of the current treatment plan shall be required. Documentation of the revised treatment plan and discussion with the patient must be recorded in the patient's chart.